IP Library Granted Patent US 12,589,254
Granted Patent B2
US 12,589,254 · App. 18/309,958 · Granted Mar 31, 2026

Wearable cardioverter defibrillator with AI-based features

Inventors: Zoie R. Engman (Kirkland, WA); Erick M. Roane (Bellevue, WA); Steven E. Sjoquist (Lynnwood, WA); Jonathan P. Niegowski (Issaquah, WA); Robert R. Buchanan (Bothell, WA)
Assignee: West Affum Holdings DAC
A61N1/3904G05B13/0265
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,589,254
App. No.
18/309,958
Granted
Mar 31, 2026
Kind
B2
Abstract

“Artificial Intelligence” or “AI” technology can be applied to Wearable Cardioverter Defibrillators (“WCDs”) and other wearable medical equipment in various ways, including garment fitting and adjustment, analyzing electrocardiogram (“ECG”), other sensor data and/or other patient data in real time to detect/assess the patient's present condition and/or need for treatment for cardiac and other conditions (e.g., stroke, coughing, apnea, etc.), detect imminent failure of the wearable medical device components, capture and report data collected from the patient for presenting to clinicians, adjust thresholds for alarms and notifications based on patient's responses, improve patient compliance based on the patient's past non-compliant behavior and actions that resulted in the patient becoming compliant, provide tests to the patient, and learn the patient's responses to detect/assess the patient's present condition and/or need for treatment.

Claims (31)

1 . A Wearable Cardioverter Defibrillator (WCD) system, comprising:

a support structure configured to be worn by a patient;

an energy storage module;

a discharge circuit coupled to the energy storage module;

a plurality of sensors configured to render a first input regarding a parameter of the patient associated with patient health, a first sensor in the plurality of sensors being operative to detect one or more physiological conditions of the patient, a second sensor in the plurality of sensors being operative to detect one or more environmental conditions, the one or more physiological conditions including at least a heart rhythm of the patient, the one or more environmental conditions including at least one of motion or location of the patient;

a data input source, in communication with a remote data provision service, configured to render a second input regarding the parameter of the patient associated with the patient health; and

one or more processors configured to:

receive the first input from the plurality of sensors and the second input from the data input source;

determine that the patient is experiencing a condition based on the received first input and the second input;

responsive to the determination that the patient is experiencing the condition, determine a baseline treatment for the condition based on the first input and the second input;

provide the first input and the second input to an Artificial Intelligence (AI) processing module, the AI processing module being configured to analyze the first input and the second input, and adjust the baseline treatment based on the analysis by the AI processing module, wherein the AI processing module is configured to adjust the baseline treatment upon determining a deterioration in the patient health; and

initiate a shock therapy to the patient by causing the discharge circuit to discharge an electrical charge from the energy storage module to the patient while the support structure is being worn by the patient, in response to the adjusted baseline treatment comprising shocking the patient.

2 . The WCD system of claim 1 , wherein the condition is informed by the one or more physiological conditions, the one or more environmental conditions, or a combination thereof.

3 . The WCD system of claim 1 , wherein the one or more physiological conditions further comprise at least a posture of the patient.

4 . The WCD system of claim 1 , wherein the condition is apnea.

5 . The WCD system of claim 1 , wherein the condition is stroke.

6 . The WCD system of claim 1 , wherein the one or more processors are further configured to provide a treatment for the condition based on the adjusted baseline treatment.

7 . The WCD system of claim 6 , wherein the treatment comprises the shock therapy.

8 . The WCD system of claim 1 , wherein the adjusted baseline treatment comprises providing a notification.

9 . The WCD system of claim 8 , wherein the notification comprises instructions to the patient, a bystander, or a remote recipient to provide a treatment.

10 . The WCD system of claim 8 , wherein the notification comprises information to enable a remote clinician to prescribe a treatment.

11 . The WCD system of claim 8 , wherein the notification comprises instructions to the patient to take a safety action.

12 . The WCD system of claim 1 , wherein the data input source is collocated with at least one of the one or more processors.

13 . The WCD system of claim 1 , wherein the one or more processors are two or more processors, and wherein a first of the two or more processors is configured to implement the AI processing module and to make the adjustments to the baseline treatment.

14 . The WCD system of claim 13 , wherein a second of the two or more processors is configured to initiate the shock therapy.

15 . The WCD system of claim 1 , wherein the condition is dizziness.

16 . The WCD system of claim 1 , wherein the WCD system further comprises a sound sensor, wherein the sound sensor is configured to sense one or more patient voice properties, and wherein the one or more patient voice properties include pitch, tone, rate, or slurring of a patient's voice.

17 . The WCD system of claim 16 , wherein the condition is informed by the one or more patient voice properties.

18 . The WCD system of claim 1 , wherein the condition is coughing.

19 . The WCD system of claim 1 , wherein the condition is seizure.

20 . The WCD system of claim 1 , wherein the first input and the second input comprise quantitative and measurable data.

Assignments (4)
SECURITY AGREEMENT Recorded Oct 4, 2023
From: WEST AFFUM HOLDINGS DESIGNATED ACTIVITY COMPANY
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 065116/0049 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2023
From: ENGMAN, ZOIE R.; ROANE, ERICK M.; SJOQUIST, STEVEN E.; NIEGOWSKI, JONATHAN P.; BUCHANAN, ROBERT R.
To: STRYKER CORP.
Reel/Frame 063939/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2023
From: WEST AFFUM HOLDINGS CORP.
To: WEST AFFUM HOLDINGS DESIGNATED ACTIVITY COMPANY
Reel/Frame 063492/0566 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2023
From: PHYSIO-CONTROL, INC.
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 063501/0670 →
Continuity (3)
Continuation 16946512 · Jun 24, 2020
Provisional Application 62865693 · Jun 24, 2019
Related Publication 20230264033A1 · Aug 24, 2023
References Cited (191)
US 3724355A · Busch et al. · 1973 [cited by applicant]
US 3724455A · Unger · 1973 [cited by applicant]
US 4583524A · Hutchins · 1986 [cited by applicant]
US 4619265A · Morgan et al. · 1986 [cited by applicant]
US 4666432A · McNeish et al. · 1987 [cited by applicant]
US 4698848A · Buckley · 1987 [cited by applicant]
US 4928690A · Heilman et al. · 1990 [cited by applicant]
US 4955381A · Way et al. · 1990 [cited by applicant]
US 5078134A · Heilman et al. · 1992 [cited by applicant]
US 5228449A · Christ et al. · 1993 [cited by applicant]
US 5348008A · Bornn et al. · 1994 [cited by applicant]
US 5353793A · Bornn · 1994 [cited by applicant]
US RE34800E · Hutchins · 1994 [cited by applicant]
US 5394892A · Kenny et al. · 1995 [cited by applicant]
US 5405362A · Kramer et al. · 1995 [cited by applicant]
US 5429593A · Matory · 1995 [cited by applicant]
US 5474574A · Payne et al. · 1995 [cited by applicant]
US 5618208A · Crouse et al. · 1997 [cited by applicant]
US 5662690A · Cole et al. · 1997 [cited by applicant]
US 5708978A · Johnsrud · 1998 [cited by applicant]
US 5741306A · Glegyak et al. · 1998 [cited by applicant]
US 5782878A · Morgan et al. · 1998 [cited by applicant]
US 5792204A · Snell · 1998 [cited by applicant]
US 5902249A · Lyster · 1999 [cited by applicant]
US 5913685A · Hutchins · 1999 [cited by applicant]
US 5944669A · Kaib · 1999 [cited by applicant]
US 6047203A · Sackner et al. · 2000 [cited by applicant]
US 6065154A · Hulings et al. · 2000 [cited by applicant]
US 6108197A · Janik · 2000 [cited by applicant]
US 6148233A · Owen et al. · 2000 [cited by applicant]
US 6201992B1 · Freeman · 2001 [cited by applicant]
US 6263238B1 · Brewer et al. · 2001 [cited by applicant]
US 6280461B1 · Glegyak et al. · 2001 [cited by applicant]
US 6287328B1 · Snyder et al. · 2001 [cited by applicant]
US 6304780B1 · Owen et al. · 2001 [cited by applicant]
US 6319011B1 · Motti et al. · 2001 [cited by applicant]
US 6334070B1 · Nova et al. · 2001 [cited by applicant]
US 6356785B1 · Snyder et al. · 2002 [cited by applicant]
US 6427083B1 · Owen et al. · 2002 [cited by applicant]
US 6437083B1 · Brack et al. · 2002 [cited by applicant]
US 6450942B1 · Lapanashvili et al. · 2002 [cited by applicant]
US 6529875B1 · Nakajima et al. · 2003 [cited by applicant]
US 6546285B1 · Owen et al. · 2003 [cited by applicant]
US 6671545B2 · Fincke · 2003 [cited by applicant]
US 6681003B2 · Linder et al. · 2004 [cited by applicant]
US 6762917B1 · Verbiest et al. · 2004 [cited by applicant]
US 7065401B2 · Worden · 2006 [cited by applicant]
US 7099715B2 · Korzinov · 2006 [cited by applicant]
US 7212850B2 · Prystowsky · 2007 [cited by applicant]
US 7559902B2 · Ting et al. · 2009 [cited by applicant]
US 7587237B2 · Korzinov · 2009 [cited by applicant]
US 7753759B2 · Pintor et al. · 2010 [cited by applicant]
US 7865238B2 · Brink · 2011 [cited by applicant]
US 7870761B2 · Valentine et al. · 2011 [cited by applicant]
US 7907996B2 · Prystowsky · 2011 [cited by applicant]
US 7941207B2 · Korzinov · 2011 [cited by applicant]
US 7974689B2 · Volpe et al. · 2011 [cited by applicant]
US 8024037B2 · Kumar · 2011 [cited by applicant]
US 8135462B2 · Owen et al. · 2012 [cited by applicant]
US 8140154B2 · Donnelly et al. · 2012 [cited by applicant]
US 8369944B2 · Macho et al. · 2013 [cited by applicant]
US 8527028B2 · Kurzweil et al. · 2013 [cited by applicant]
US 8548557B2 · Garstka et al. · 2013 [cited by applicant]
US 8560044B2 · Kurzweil et al. · 2013 [cited by applicant]
US 8615295B2 · Savage et al. · 2013 [cited by applicant]
US 8644925B2 · Volpe et al. · 2014 [cited by applicant]
US 8676313B2 · Volpe et al. · 2014 [cited by applicant]
US 8706255B2 · Phillips et al. · 2014 [cited by applicant]
US 8742349B2 · Urbon et al. · 2014 [cited by applicant]
US 8897860B2 · Volpe et al. · 2014 [cited by applicant]
US 8904214B2 · Volpe et al. · 2014 [cited by applicant]
US 8965500B2 · Macho et al. · 2015 [cited by applicant]
US 9008801B2 · Kaib et al. · 2015 [cited by applicant]
US 9084583B2 · Mazar et al. · 2015 [cited by applicant]
US 9089685B2 · Sullivan et al. · 2015 [cited by applicant]
US 9119547B2 · Cazares et al. · 2015 [cited by applicant]
US 9131901B2 · Volpe et al. · 2015 [cited by applicant]
US 9132267B2 · Kaib · 2015 [cited by applicant]
US 9265432B2 · Warren et al. · 2016 [cited by applicant]
US 9345898B2 · Piha et al. · 2016 [cited by applicant]
US 9408548B2 · Volpe et al. · 2016 [cited by applicant]
US 9445719B2 · Libbus et al. · 2016 [cited by applicant]
US 9454219B2 · Volpe et al. · 2016 [cited by applicant]
US 9579020B2 · Libbus et al. · 2017 [cited by applicant]
US 9592403B2 · Sullivan · 2017 [cited by applicant]
US 9598799B2 · Shoshani et al. · 2017 [cited by applicant]
US 9675804B2 · Whiting et al. · 2017 [cited by applicant]
US 9724008B2 · Sullivan et al. · 2017 [cited by applicant]
US 9757581B2 · Sullivan et al. · 2017 [cited by applicant]
US 9878171B2 · Kaib · 2018 [cited by applicant]
US 9895105B2 · Romem · 2018 [cited by applicant]
US 9901741B2 · Chapman et al. · 2018 [cited by applicant]
US RE46926E · Bly et al. · 2018 [cited by applicant]
US 10016613B2 · Kavounas · 2018 [cited by applicant]
US 10076656B2 · Dar et al. · 2018 [cited by applicant]
US 10192387B2 · Brinig et al. · 2019 [cited by applicant]
US 10307133B2 · Kaib · 2019 [cited by applicant]
US 10463867B2 · Kaib et al. · 2019 [cited by applicant]
US 10589110B2 · Oskin et al. · 2020 [cited by applicant]
US 10599814B2 · Landrum et al. · 2020 [cited by applicant]
US 11133112B2 · Teplitzky et al. · 2021 [cited by applicant]
US 11672996B2 · Engman · 2023 [cited by examiner]
US 20020181680A1 · Linder et al. · 2002 [cited by applicant]
US 20030158593A1 · Heilman et al. · 2003 [cited by applicant]
US 20050107833A1 · Freeman et al. · 2005 [cited by applicant]
US 20050107834A1 · Freeman et al. · 2005 [cited by applicant]
US 20060173499A1 · Hampton et al. · 2006 [cited by applicant]
US 20080312709A1 · Vollpe et al. · 2008 [cited by applicant]
US 20090005827A1 · Weintraub et al. · 2009 [cited by applicant]
US 20100007413A1 · Herleikson et al. · 2010 [cited by applicant]
US 20100298899A1 · Donnelly et al. · 2010 [cited by applicant]
US 20110022105A9 · Owen et al. · 2011 [cited by applicant]
US 20110288604A1 · Kaib et al. · 2011 [cited by applicant]
US 20110288605A1 · Kaib et al. · 2011 [cited by applicant]
US 20120112903A1 · Kaib et al. · 2012 [cited by applicant]
US 20120144551A1 · Guldalian · 2012 [cited by applicant]
US 20120150008A1 · Kaib et al. · 2012 [cited by applicant]
US 20120158075A1 · Kaib et al. · 2012 [cited by applicant]
US 20120191476A1 · Reid et al. · 2012 [cited by applicant]
US 20120265265A1 · Razavi et al. · 2012 [cited by applicant]
US 20120283794A1 · Kaib et al. · 2012 [cited by applicant]
US 20120293323A1 · Kaib et al. · 2012 [cited by applicant]
US 20120302860A1 · Volpe et al. · 2012 [cited by applicant]
US 20120310315A1 · Savage et al. · 2012 [cited by applicant]
US 20130085538A1 · Volpe et al. · 2013 [cited by applicant]
US 20130144355A1 · Macho et al. · 2013 [cited by applicant]
US 20130231711A1 · Kaib · 2013 [cited by applicant]
US 20130245388A1 · Rafferty et al. · 2013 [cited by applicant]
US 20130274565A1 · Langer et al. · 2013 [cited by applicant]
US 20130317852A1 · Worrell et al. · 2013 [cited by applicant]
US 20130325078A1 · Whiting et al. · 2013 [cited by applicant]
US 20140012144A1 · Crone · 2014 [cited by applicant]
US 20140025131A1 · Sullivan et al. · 2014 [cited by applicant]
US 20140043149A1 · Cowan et al. · 2014 [cited by applicant]
US 20140046391A1 · Cowan et al. · 2014 [cited by applicant]
US 20140070957A1 · Longinotti-Buitoni et al. · 2014 [cited by applicant]
US 20140163663A1 · Poddar et al. · 2014 [cited by applicant]
US 20140324112A1 · Macho et al. · 2014 [cited by applicant]
US 20140378812A1 · Saroka et al. · 2014 [cited by applicant]
US 20150039053A1 · Kaib et al. · 2015 [cited by applicant]
US 20150161554A1 · Sweeney et al. · 2015 [cited by applicant]
US 20150297135A1 · Shoshani et al. · 2015 [cited by applicant]
US 20150328472A1 · Sullivan et al. · 2015 [cited by applicant]
US 20160004831A1 · Carlson et al. · 2016 [cited by applicant]
US 20160076175A1 · Rock et al. · 2016 [cited by applicant]
US 20160076176A1 · Rock et al. · 2016 [cited by applicant]
US 20160082277A1 · Foshee, Jr. et al. · 2016 [cited by applicant]
US 20160113581A1 · Amir et al. · 2016 [cited by applicant]
US 20160135706A1 · Sullivan et al. · 2016 [cited by applicant]
US 20160256104A1 · Romem et al. · 2016 [cited by applicant]
US 20160283900A1 · Johnson et al. · 2016 [cited by applicant]
US 20160303371A1 · Whiting et al. · 2016 [cited by applicant]
US 20170014073A1 · Shoshani et al. · 2017 [cited by applicant]
US 20170027469A1 · Amir et al. · 2017 [cited by applicant]
US 20170036066A1 · Chahine · 2017 [cited by applicant]
US 20170040758A1 · Amir et al. · 2017 [cited by applicant]
US 20170056682A1 · Kumar et al. · 2017 [cited by applicant]
US 20170162840A1 · Pendry · 2017 [cited by applicant]
US 20170319862A1 · Foshee, Jr. et al. · 2017 [cited by applicant]
US 20170367591A1 · Jorgensen · 2017 [cited by applicant]
US 20180116537A1 · Sullivan et al. · 2018 [cited by applicant]
US 20180117299A1 · Gustavson et al. · 2018 [cited by applicant]
US 20180184933A1 · Sullivan et al. · 2018 [cited by applicant]
US 20180185662A1 · Foshee, Jr. et al. · 2018 [cited by applicant]
US 20180243578A1 · Volosin · 2018 [cited by applicant]
US 20180348759A1 · Freeman et al. · 2018 [cited by applicant]
US 20180361165A1 · Jaax et al. · 2018 [cited by applicant]
US 20190030351A1 · Sullivan et al. · 2019 [cited by applicant]
US 20190030352A1 · Sullivan et al. · 2019 [cited by applicant]
US 20190076666A1 · Medema · 2019 [cited by applicant]
US 20190116896A1 · Armour et al. · 2019 [cited by applicant]
US 20190321650A1 · Raymond et al. · 2019 [cited by applicant]
US 20200398065A1 · Engman et al. · 2020 [cited by applicant]
DE 2005060985A2 · 2007 [cited by applicant]
EP 2305110A1 · 2011 [cited by applicant]
JP 4320257A · 2005 [cited by applicant]
JP 5963767A · 2014 [cited by applicant]
JP 2014526282A · 2014 [cited by applicant]
WO 9839061A2 · 1998 [cited by applicant]
WO 2011146448A1 · 2011 [cited by applicant]
WO 2012064604A1 · 2012 [cited by applicant]
WO 2012151160A1 · 2012 [cited by applicant]
WO 2015056262A1 · 2015 [cited by applicant]
Heartstart MRx and XL AED Algorithm-Application Note, Jul. 2001, Edition 2 Philips Healthcare, USA. [cited by applicant]
Klein, H. U., Goldenberg, I., and Moss, A. J., “Risk Stratification for Implantable Cardioverter Defibrillator Therapy: The Role of the Wearable Cardioverter-Defibrillator, Clinical update,” European Heart Journal, May … [cited by applicant]
LIFECOR LifeVest System Model WCD 3100 Operator's Manual, 2006, PN 20B0040 Rev FI, Zoll Lifecor Corporation, Pittsburgh, PA. [cited by applicant]
LifeVest Model 4000 Patient Manual, Zoll, 2009, PN 20B0047 Rev B. [cited by applicant]
Pagan-Carlo, et al., “Encircling Overlapping Multipulse Shock Waveforms for Transthoracic Defibrillation,” JACC Journals, Dec. 1998, vol. 32 Issue 7, p. 2065-2071. [cited by applicant]
The LifeVest Network/Patient Data Management System, Zoll, 2015, 2000503 Rev A. [cited by applicant]
Zoll, LifeVest, Proven protection from Sudden Cardiac Death, issued Mar. 27, 2018, 4 pages. Pittsburgh PA, USA. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2015/051726, dated May 20, 2016, European Patent Office, Rijswijk, 11 pages. [cited by applicant]